• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理性随机行走:复制保护性抗体轨迹。

Rationalizing Random Walks: Replicating Protective Antibody Trajectories.

机构信息

Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.

Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA; Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.

出版信息

Trends Immunol. 2021 Mar;42(3):186-197. doi: 10.1016/j.it.2021.01.001. Epub 2021 Jan 26.

DOI:10.1016/j.it.2021.01.001
PMID:33514459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7914221/
Abstract

'Reverse vaccinology 2.0' aims to rationally reproduce template antibody responses, such as broadly neutralizing antibodies against human immunodeficiency virus-1. While observations of antibody convergence across individuals support the assumption that responses may be replicated, the diversity of humoral immunity and the process of antibody selection are rooted in stochasticity. Drawing from experience with in vitro antibody engineering by directed evolution, we consider how antibody selection may be driven, as in germline-targeting vaccine approaches to elicit broadly neutralizing antibodies and illustrate the potential consequences of over-defining a template antibody response. We posit that the prospective definition of template antibody responses and the odds of replicating them must be considered within the randomness of humoral immunity.

摘要

“反向疫苗学 2.0”旨在合理复制模板抗体反应,例如针对人类免疫缺陷病毒-1 的广泛中和抗体。虽然个体之间的抗体趋同观察支持可以复制反应的假设,但体液免疫的多样性和抗体选择的过程都源于随机性。借鉴体外抗体定向进化工程的经验,我们考虑抗体选择可能受到哪些因素的驱动,例如针对种系的疫苗方法来诱导广泛中和抗体,并说明过度定义模板抗体反应的潜在后果。我们假设,在体液免疫的随机性范围内,必须考虑到模板抗体反应的前瞻性定义及其复制的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/7914221/4655bd5f97ab/nihms-1661674-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/7914221/0dbde94ee49d/nihms-1661674-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/7914221/2e6dfe840a00/nihms-1661674-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/7914221/4655bd5f97ab/nihms-1661674-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/7914221/0dbde94ee49d/nihms-1661674-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/7914221/2e6dfe840a00/nihms-1661674-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/7914221/4655bd5f97ab/nihms-1661674-f0003.jpg

相似文献

1
Rationalizing Random Walks: Replicating Protective Antibody Trajectories.理性随机行走:复制保护性抗体轨迹。
Trends Immunol. 2021 Mar;42(3):186-197. doi: 10.1016/j.it.2021.01.001. Epub 2021 Jan 26.
2
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.非人灵长类动物免疫接种引发的HIV-1交叉反应性原发性病毒中和抗体反应
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00910-17. Print 2017 Nov 1.
3
Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.广泛中和抗体在预防HIV-1感染黏膜组织方面显示出优于非中和抗体的潜力。
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01762-16. Print 2017 Jan 1.
4
Toward an antibody-based HIV-1 vaccine.朝着基于抗体的 HIV-1 疫苗努力。
Annu Rev Med. 2010;61:135-52. doi: 10.1146/annurev.med.60.042507.164323.
5
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution.HIV-1 对中和抗体的耐药性:确定导致逃逸突变体进化的抗体浓度。
Virus Res. 2016 Jun 15;218:57-70. doi: 10.1016/j.virusres.2015.10.009. Epub 2015 Oct 19.
6
Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.广泛中和抗体及抗病毒试剂单独或联合使用对游离型和细胞间HIV-1传播的抑制作用
J Virol. 2015 Aug;89(15):7813-28. doi: 10.1128/JVI.00783-15. Epub 2015 May 20.
7
Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers.在多价支架和类天然 gp140 三聚体背景下对保守 HIV-1 中和表位的差异抗体反应
mBio. 2017 Feb 28;8(1):e00036-17. doi: 10.1128/mBio.00036-17.
8
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.在兔和恒河猴动物模型中桥接疫苗诱导的 HIV-1 中和和效应抗体反应。
J Virol. 2019 May 1;93(10). doi: 10.1128/JVI.02119-18. Print 2019 May 15.
9
Env-2dCD4 S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1).Env-2dCD4 S60C复合物作为超级免疫原,可引发针对临床相关的1型人类免疫缺陷病毒(HIV-1)的强效、广泛中和抗体。
Vaccine. 2015 Nov 17;33(46):6298-306. doi: 10.1016/j.vaccine.2015.09.056. Epub 2015 Oct 1.
10
Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines.通过嵌合减毒活甲型流感病毒疫苗诱导针对HIV-1包膜蛋白膜近端外部区域的中和抗体。
Vaccine. 2015 Jul 31;33(32):3859-64. doi: 10.1016/j.vaccine.2015.06.072. Epub 2015 Jun 28.

引用本文的文献

1
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.mRNA-LNP HIV-1 三聚体增强剂引发广谱中和抗体前体。
Science. 2024 May 17;384(6697):eadk0582. doi: 10.1126/science.adk0582.
2
Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn.IgG抗体滴度及亚型在新生儿溶血病诊断和病情严重程度评估中的应用
Transl Pediatr. 2022 Sep;11(9):1544-1551. doi: 10.21037/tp-22-385.
3
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers.

本文引用的文献

1
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.表达真实的人类 VRC01 类 BCR 的 B 细胞可以在多个独立的小鼠模型中被招募到生发中心并进行亲和力成熟。
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22920-22931. doi: 10.1073/pnas.2004489117. Epub 2020 Sep 1.
2
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo.抗原价态对体内 B 细胞反应组成和分化的多方面影响。
Immunity. 2020 Sep 15;53(3):548-563.e8. doi: 10.1016/j.immuni.2020.08.001. Epub 2020 Aug 27.
3
A Bayesian phylogenetic hidden Markov model for B cell receptor sequence analysis.
递送膜锚定的天然样HIV-1包膜三聚体的整合酶缺陷型慢病毒载体的持续免疫原性。
NPJ Vaccines. 2022 Apr 21;7(1):44. doi: 10.1038/s41541-022-00465-1.
用于 B 细胞受体序列分析的贝叶斯系统发育隐马尔可夫模型。
PLoS Comput Biol. 2020 Aug 17;16(8):e1008030. doi: 10.1371/journal.pcbi.1008030. eCollection 2020 Aug.
4
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.人类抗体与 SARS-CoV-2 刺突结合的结构揭示了常见表位和抗体的反复出现特征。
Cell. 2020 Aug 20;182(4):828-842.e16. doi: 10.1016/j.cell.2020.06.025. Epub 2020 Jun 24.
5
Convergent antibody responses to SARS-CoV-2 in convalescent individuals.恢复期患者体内对 SARS-CoV-2 的趋同抗体反应
Nature. 2020 Aug;584(7821):437-442. doi: 10.1038/s41586-020-2456-9. Epub 2020 Jun 18.
6
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.来自 COVID-19 患者的强效中和抗体定义了多个易损目标。
Science. 2020 Aug 7;369(6504):643-650. doi: 10.1126/science.abc5902. Epub 2020 Jun 15.
7
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.高通量单细胞测序鉴定恢复期患者 B 细胞中的 SARS-CoV-2 强效中和抗体。
Cell. 2020 Jul 9;182(1):73-84.e16. doi: 10.1016/j.cell.2020.05.025. Epub 2020 May 18.
8
De novo protein design enables the precise induction of RSV-neutralizing antibodies.从头设计蛋白质可精确诱导 RSV 中和抗体。
Science. 2020 May 15;368(6492). doi: 10.1126/science.aay5051.
9
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.SARS-CoV-2 和 SARS 冠状病毒受体结合域中高度保守的隐蔽表位。
Science. 2020 May 8;368(6491):630-633. doi: 10.1126/science.abb7269. Epub 2020 Apr 3.
10
Next-Generation Influenza Vaccines.下一代流感疫苗。
Cold Spring Harb Perspect Med. 2021 Aug 2;11(8):a038448. doi: 10.1101/cshperspect.a038448.